Evidence map›Paper›PMID 39770040›Full record

ReviewMolecules (Basel, Switzerland)2024

Natural Products as Modulators of Aryl Hydrocarbon Receptor Signaling in Atopic Dermatitis Management.

Jangho Lee, Hyo-Kyoung Choi, Hee Soon Shin, Gun-Dong Kim

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. CommensalFrontiers in immunology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jangho LeeDivision of Food Functionality Research, Korea Food Research Institute (KFRI), Wanju 55365, Republic of Korea.ORCID 0000-0002-5604-821X
Hyo-Kyoung ChoiDivision of Food Functionality Research, Korea Food Research Institute (KFRI), Wanju 55365, Republic of Korea.
Hee Soon ShinDivision of Food Functionality Research, Korea Food Research Institute (KFRI), Wanju 55365, Republic of Korea.ORCID 0000-0002-0942-7161
Gun-Dong KimDivision of Food Functionality Research, Korea Food Research Institute (KFRI), Wanju 55365, Republic of Korea.

Funding

Korea Food Research Institute E0210400-04
6 · The paper itself

Abstract

Atopic dermatitis (AD) is a chronic inflammatory skin condition characterized by immune dysregulation, skin barrier dysfunction, and a significant patient burden. Recent studies have highlighted the aryl hydrocarbon receptor (AhR) as a promising therapeutic target for AD management because of its pivotal role in modulating immune responses and maintaining skin barrier integrity. The dysfunction of the AhR pathway has been linked to AD pathogenesis, emphasizing the need for therapies that can restore its regulatory functions. Natural products have emerged as potential modulators of the AhR and are effective and safe alternatives to conventional treatments. Compounds such as curcumin, resveratrol, quercetin, and microbial metabolites have demonstrated the ability to activate AhR, reduce inflammation, and promote skin barrier function. These natural agents have fewer side effects and enhance patient compliance compared with conventional therapies, making them attractive candidates for long-term AD management. The integration of natural products targeting the AhR pathway provides a multifaceted approach that alleviates symptoms, addresses underlying disease mechanisms, and promotes sustainable improvements in skin health. This review highlights the therapeutic potential of natural AhR modulators and their potential roles in enhancing patient outcomes through novel integrative treatment strategies.

Indexed as

Biological ProductsDermatitis, AtopicReceptors, Aryl HydrocarbonSignal TransductionAnimalsHumansBiological ProductsReceptors, Aryl Hydrocarbonaryl hydrocarbon receptoratopic dermatitisimmune modulationnatural productskin barrier function

Identifiers

PMID39770040
PMCPMC11678720

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.